The effect of polyclonal antibody against fibronectin on von Willebrand Factor multimeric size

Thrombosis Research

Volumn 96, Issue 2, 1999, Pages 161-167

  Kempfer, Ana C ^b   Farías, Cristina E ^b   Carballo, Gonzalo A ^a   Silaf, María R ^a   Lazzari, María A ^a,b  

^a INST DE INVEST HEMATOLOGICAS   (Argentina)

^b Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

Antibodies against fibronectin; Shear rate; von Willebrand factor

Indexed keywords

AMYLOID PROTEIN; CERULOPLASMIN; FIBRONECTIN; POLYCLONAL ANTIBODY; POLYMER; VON WILLEBRAND FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; METHODOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; SHEAR RATE; THROMBOCYTE AGGREGATION;

ANTIBODY SPECIFICITY; FIBRONECTINS; HUMANS; IMMUNOBLOTTING; MACROMOLECULAR SUBSTANCES; PRECIPITIN TESTS; VON WILLEBRAND FACTOR;

EID: 0344131405     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00098-5     Document Type: Article

References (27)

1. Shelton-Inloes B.B., Titani K., Sadler J.E. cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms. Biochem. 25:1986;3164-3171.
2. Titani K., Kumar S., Takio K., Ericsson L.H., Wade R.D., Ashida K., Walsh K.A., Chopek M.W., Sadler J.E., Fujikawa K. Amino acid sequence of human von Willebrand factor. Biochem. 25:1986;3171-3184.
3. Doucet-de Bruine M.H.M., Sixma J.J., Over J., Beeser-Visser N.H. Heterogeneity of human factor VIII. II Characterization of forms of factor VIII binding to platelets in the presence of ristocetin. J Lab Clin Med. 92:1978;96-107.
4. Kessler C.M., Floyd C.M., Rick M.E., Krizek D.M., Lee S.L., Gralnick H.R. Collagen-Factor VIII/von Willebrand factor protein interaction. Blood. 63:1984;1291-1296.
5. Turitto V.T., Weiss H.J., Zimmerman T.S., Sussman H. Factor VIII/vWf in subendothelium mediates platelet adhesion. Blood. 65:1985;823-831.
6. Stel H.V., Sakariassen K.S., deGroot P.G., van Mourik J.A., Sixma J.J. vWf in the vessel wall mediates platelet adherence. Blood. 65:1985;85-90.
7. Moake J.L., Turner N.A., Stathopoulos N.A., Nolasco L.H., Hellmus J.D. Involvement of large plasma von Willebrand factor (vWf) multimers and unusually large forms derived from endothelial cells in shear stress-induced platelet aggregation. J Clin Invest. 78:1986;1456-1461.
8. Moake J.L., Turner N.A., Stathopoulos N.A., Nolasco L.H., Hellmus J.D. Shear-induced platelet aggregation can be mediated by vWf released from platelets, as well as by exogenous large or unusually large vWf multimers, requires adenosine diphosphate, and is resistant to aspirin. Blood. 71:1988;1366-1374.
9. Peterson D.M., Stathopoulos N.A., Giorgio T.D., Hellmus J.D., Moake J.L. Shear-induced platelet aggregation requires von Willebrand factor and platelet membrane glycoproteins Ib and IIb-IIIa. Blood. 69:1987;625-628.
10. Ikeda Y., Handa M., Kawano K.et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest. 87:1991;1234-1240.
11. Phillips M.D., Moake J.L., Nolasco L., García R. Plasma von Willebrand factor processing activity functions like a disulfide bond reductase. Reversible decrease of multimer size Thromb Haemostas. 69:1993;2342. (abstract).
12. Tsai H.M., Sussman I.I., Nagel R.L. Shear stress enhances the proteolysis of von Willebrand factor in normal plasma. Blood. 83:1994;2171-2179.
13. Kempfer A.C., Farías C., Woods A., Cardozo M.A., Lazzari M.A. The effect of high wall shear rate and a plasma fraction on von Willebrand factor multimers size. Thromb Haemost. 73:1995;1165. (abstract).
14. Furlan M., Robles R., Lämmle B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 87:1996;4223-4234.
15. Kempfer A.C., Farías C.E., Lazzari M.A. Loss of large vWf multimers induced by high wall shear rate. Requirement of a plasma fraction and effect of protease inhibitors. Medicina. 57:1997;409-416.
16. Tsai H.M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 87:1996;4235-4244.
17. Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem. 15:1996;45-52.
18. Adams G.A. Platelet adhesion. Past and present Longenecker G.L. The platelets. Physiology and Pharmacology:1981;15-34 Academic Press Inc, Orlando, FL.
19. Farias C., Kempfer A.C., Blanco A., Woods A., Lazzari M.A. Visualization of the multimeric structure of von Willebrand factor by immunoenzymatic stain using avidin-peroxidase complex instead of avidin-biotin peroxidase complex. Thromb Res. 53:1989;513-518.
20. Thorell L., Blombäck B. Purification of the factor VIII complex. Thromb Res. 35:1984;431-439.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
22. De Beer F.C., Baltz M.L., Holford S., Feinstein A., Pepys M.B. Fibronectin and C4-binding protein are selectively bound aggregated amyloid P component. J Exp Med. 154:1981;1134-1149.
23. Karpatkin S., Pearlstein E., Ambrogio C., Coller B.S. Role of adhesive proteins in platelet tumor interaction in vitro and metastasis. J Clin Invest. 81:1988;1012-1019.
24. Keil-Dlouha V., Planchenault T. Potential proteolytic activity of human fibronectin. Proc Natl Acad Sci USA. 83:1986;5377-5381.
25. Lambert Vidmar S., Lottspeich F., Emod I., Planchenault T., Keil-Dlouha V. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin. Eur J Biochem. 201:1991;71-77.
26. Johansson S., Smedsrod B. Identification of a plasma gelatinase in preparations of fibronectin. J Biol Chem. 261:1986;4363-4366.
27. Lambert Vidmar S., Lottspeich F., Emod I., Imhoff J.M., Keil-Dlouha V. Collagen-binding domain of human fibronectin contains a latent type-IV collagenase. Eur J Biochem. 201:1991;79-84. b.